| 000 | 01636 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513112154.0 | ||
| 264 | 0 | _c19970306 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a0020-7136 | ||
| 024 | 7 |
_a10.1002/(sici)1097-0215(19970127)70:3<323::aid-ijc13>3.0.co;2-g _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlisauskas, R M | |
| 245 | 0 | 0 |
_aReduction in the duration of myelotoxicity associated with radioimmunotherapy with infusions of the hemoregulatory peptide, HP5b in mice. _h[electronic resource] |
| 260 |
_bInternational journal of cancer _cJan 1997 |
||
| 300 |
_a323-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBone Marrow _xdrug effects |
| 650 | 0 | 4 | _aColony-Forming Units Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xpharmacology |
| 650 | 0 | 4 |
_aGrowth Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHematopoiesis _xdrug effects |
| 650 | 0 | 4 |
_aInterleukin-1 _xpharmacology |
| 650 | 0 | 4 |
_aLeukocyte Count _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aOligopeptides _xpharmacology |
| 650 | 0 | 4 |
_aPyrrolidonecarboxylic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aRadioimmunotherapy _xadverse effects |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aGoldenberg, D M | |
| 700 | 1 | _aSharkey, R M | |
| 700 | 1 | _aBlumenthal, R D | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 70 _gno. 3 _gp. 323-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1097-0215(19970127)70:3<323::aid-ijc13>3.0.co;2-g _zAvailable from publisher's website |
| 999 |
_c9022687 _d9022687 |
||